600+ sources. One page. See who else covered it.
Shefali Agarwal works constantly. “I’m very passionate about what I do. I love getting good drugs to patients, so I work a lot,” Agarwal, the US-based CEO of Sironax, said in a December 2025 interview ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A basic bias in how the brain processes self-relevant information might contribute to severe body image preoccupations. New research shows that individuals with body dysmorphic traits learn and…
by Junjie Lin, Mika Kivimäki, Zifan Zhang, Hui Wang, Yangyang Cheng, Xiaolin Xu Background Impairments in physical, psychological, and cognitive functioning are associated with an increased risk of…
by Angeliki Apostolou, Reuben Simfukwe, Adrias Saint, Bridget Mushani, Hannah Chekhchar, Pearl Aovare, Kouamivi M. Agboyibor, Karlijn A. C. Meeks, George F. Mkoma, Charles Agyemang, Felix P.
The transaction combines two companies marketing nearly a dozen neurological drugs that bring in steady, but not blockbuster sales for conditions such as opioid use disorder and Parkinson's.
In a clinical trial of adults with HIV-related cryptococcal disease, those treated with a two-drug combination had a 21% lower risk of dying than those treated with just one drug.
While Black and Hispanic families are enthusiastic about research participation, other provider- and system-focused factors may influence their involvement in pediatric oncology clinical trials, a UT…